Greg Gregory

Greg Gregory, PhD, is a seasoned executive in the pharmaceutical consulting industry, currently serving as Executive Vice President and Managing Director at Precision AQ since January 2024. Previously, Greg held senior leadership roles at PRECISIONadvisors from April 2020 to December 2023 and at Precision Xtract from July 2018 to April 2020, where responsibilities included operations, growth, and thought leadership in rare diseases, vaccines, and digital therapeutics. Greg began a career in consulting at inVentiv Health Consulting, progressing from Analyst to Senior Engagement Manager, and has a solid background in healthcare through experiences such as a postdoctoral fellowship at The Children’s Hospital of Philadelphia and a consultancy role at Penn Biotech Group. Educated at Emory University with a PhD in Immunology and Molecular Pathogenesis, Greg also holds a BS in Microbiology from the University of Rochester.